» Authors » Francesco Fracassi

Francesco Fracassi

Explore the profile of Francesco Fracassi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 941
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bianchini F, Romagnoli E, Aurigemma C, Paraggio L, Buffon A, Fracassi F, et al.
JACC Cardiovasc Interv . 2025 Mar; PMID: 40071321
Background: "Stepwise provisional stenting" is the most adopted approach for percutaneous coronary interventions (PCI) in bifurcation lesions. During these procedures, side-branch (SB) may deserve treatment, but the best ballooning technique...
2.
Cappannoli L, Colantuono S, Animati F, Fracassi F, Galli M, Aurigemma C, et al.
Biomolecules . 2024 Oct; 14(10). PMID: 39456262
Acetylsalicylic acid (ASA) represents a cornerstone of antiplatelet therapy for the treatment of atherosclerotic coronary artery disease (CAD). ASA is in fact indicated in case of an acute coronary syndrome...
3.
Covella S, Armenise V, Okash Ur Rehman M, Aktas E, Fracassi F, Palumbo F, et al.
ACS Appl Mater Interfaces . 2024 Sep; 16(37):49392-49399. PMID: 39230387
Tin halide perovskites represent the most suitable alternative to their lead-based counterparts for sustainable photovoltaics. One of the most important drawbacks of this class of materials is the intrinsic tendency...
4.
Cappannoli L, Galli M, Borovac J, Valeriani E, Animati F, Fracassi F, et al.
Front Cardiovasc Med . 2024 Aug; 11:1469413. PMID: 39211770
No abstract available.
5.
Bianchini E, Basile M, Bianchini F, Zito A, Romagnoli E, Aurigemma C, et al.
Int J Cardiol . 2024 Jul; 413:132392. PMID: 39067526
Background: Patients experiencing non-ST segment elevation acute-coronary-syndromes (NSTE-ACS) often present with multivessel-coronary-artery-disease (MVD). An immediate complete multivessel revascularization (MVR) - within the index hospitalization - may be considered the default...
6.
Fracassi F, Animati F, Cappannoli L, Burzotta F
Int J Cardiol . 2024 May; 409:132157. PMID: 38754584
No abstract available.
7.
Araki M, Park S, Dauerman H, Uemura S, Kim J, Di Mario C, et al.
Nat Rev Cardiol . 2023 Dec; 21(5):348. PMID: 38110566
No abstract available.
8.
Petrolati E, Montone R, Leone A, Ricchiuto A, La Vecchia G, Rinaldi R, et al.
G Ital Cardiol (Rome) . 2023 Sep; 24(10 Suppl 2):21S-28S. PMID: 37767844
Myocardial infarction with non-obstructive coronary artery disease (MINOCA) is a heterogeneous clinical condition affecting 5% to 8% of patients presenting with acute myocardial infarction. Initially it was considered a favorable...
9.
Veronico V, Morelli S, Piscioneri A, Gristina R, Casiello M, Favia P, et al.
ACS Omega . 2023 Sep; 8(37):33723-33736. PMID: 37744835
Water solutions treated by cold atmospheric plasmas (CAPs) currently stand out in the field of cancer treatment as sources of exogenous blends of reactive oxygen and nitrogen species (RONS). It...
10.
Del Sole R, Lo Porto C, Lotito S, Ingrosso C, Comparelli R, Curri M, et al.
Molecules . 2023 Jul; 28(13). PMID: 37446794
Among the different applications of TiO, its use for the photocatalytic abatement of organic pollutants has been demonstrated particularly relevant. However, the wide band gap (3.2 eV), which requires UV...